
COVID-19 - November 5, 2021
Merck’s COVID-19 pill approved in the UK
Merck and Ridgeback’s Molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world. U.K.’s Medicines and Healthcare Products Regulatory Agency authorizes Molnupiravir for the treatment of mild-to-moderate COVID-19 in adults with a positive SARS-CoV-2 diagnostic test and who have at least one risk factor for developing severe illness. In the U.K., LAGEVRIO (lah-GEV-ree-oh) is […]